https://www.lytgobi.com https://www.lytgobi.com/static/img/lytgobi-futibatinib-logo.svg https://www.lytgobi.com/about-bile-duct-cancer https://www.lytgobi.com/static/img/extrahepatic-and-intrahepatic-bile-duct-cancer.png https://www.lytgobi.com/how-lytgobi-works https://www.lytgobi.com/static/img/lytgobi-blocking-fgfr2-receptors.png https://www.lytgobi.com/treatment-with-lytgobi/how-lytgobi-can-help https://www.lytgobi.com/treatment-with-lytgobi/side-effects https://www.lytgobi.com/how-to-take-lytgobi https://www.lytgobi.com/static/img/lytgobi-tablets-exterior-packaging.png https://www.lytgobi.com/support-resources/cost-assistance https://www.lytgobi.com/static/img/co-pay-card.png https://www.lytgobi.com/support-resources/patient-resources https://www.lytgobi.com/static/img/lytgobi-patient-access-guide.png https://www.lytgobi.com/hcp https://www.lytgobi.com/static/img/lytgobi-futibatinib-logo.svg https://www.lytgobi.com/hcp/cholangiocarcinoma-challenges https://www.lytgobi.com/hcp/mechanism-of-action https://www.lytgobi.com/static/img/targeting-fgfr-in-cholangiocarcinoma.png https://www.lytgobi.com/hcp/efficacy-and-safety/study-design https://www.lytgobi.com/hcp/efficacy-and-safety/efficacy-results https://www.lytgobi.com/static/img/lytgobi-disease-control-rate.svg https://www.lytgobi.com/hcp/efficacy-and-safety/safety-profile https://www.lytgobi.com/hcp/dosing/dosing-and-administration https://www.lytgobi.com/static/img/lytgobi-tablets-interior-packaging.png https://www.lytgobi.com/hcp/dosing/dosage-modifications https://www.lytgobi.com/hcp/resources/professional-resources https://www.lytgobi.com/hcp/resources/patient-support-services https://www.lytgobi.com/static/img/co-pay-card.png https://www.lytgobi.com/hcp/resources/icd-10-codes